Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Somatics is a private medical device company focused on electroconvulsive therapy equipment for psychiatric care. The company manufactures and markets the Thymatron ECT system, an FDA-cleared device used to treat catatonia and severe treatment-resistant major depressive episodes associated with major depressive disorder or bipolar disorder in patients aged 13 years and older. In addition to the core Thymatron device, Somatics sells related consumables, accessories, educational materials, and GPD software for treatment workflow, trace monitoring, patient database functions, and HL7-compatible EHR interfacing. The business appears to operate as a specialized commercial-stage mental health technology supplier rather than a drug-development biotech company. Its products are used globally through a distributor network serving psychiatric facilities and clinicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Somatics.